The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail to firstname.lastname@example.org. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395-6974. Written comments should be received within 30 days of this notice.
Adult and Pediatric HIV/AIDS Confidential Case Reports (OMB Control No. 0920-0573)—Revision-National Center for HIV, STD, and TB Prevention (NCHSTP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC is seeking a three-year OMB approval to continue data collection of the HIV/AIDS case reports with revision of currently approved data collection. Revisions include additional data elements on testing and treatment, specimen quality and sequence information for drug resistance and HIV-1 subtypes, and clinical and behavioral information on HIV-infected mothers and their infants.
The National Adult and Pediatric HIV/AIDS Confidential Case Reports are collected as part of the HIV/AIDS Surveillance System. CDC, in collaboration with health departments in 59 reporting areas (states, territories, possessions, and the District of Columbia), conducts national surveillance for cases of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS), the end-stage of disease caused by infection with HIV. HIV/AIDS surveillance data collection by CDC is authorized and protected under Section 306 of the Public Health Service Act (42 U.S.C. 242k).
Currently, all 59 areas mandate and collect AIDS surveillance data. In addition, 50 of the areas currently mandate and collect confidential name-based surveillance data on HIV cases which have not progressed to AIDS. The Adult HIV/AIDS Confidential Case Report form is used for patients ≥ 13 years of age. The Pediatric HIV/AIDS Confidential Case Report form is used for patients ≤ twelve years of age at the time of diagnosis. We anticipate that over the next three years all 59 areas will mandate collection of confidential name-based HIV surveillance data. Therefore, the estimated burden for the next three years is based on HIV case reporting in 59 areas.
The purpose of HIV/AIDS surveillance data is to monitor trends in HIV/AIDS and describe the characteristics of infected persons (e.g., demographics, risk behaviors, clinical and laboratory markers of HIV disease, manifestations of severe HIV disease, and deaths due to AIDS). Because HIV infection results in untimely death and most often infects younger adults in the prime years of life, large amounts of Federal, State, and local government funding have been allocated to address all aspects of HIV infection, including prevention and treatment. HIV/AIDS surveillance data are the only nationally available data on persons reported with HIV and AIDS and are widely used at all government levels to assess the impact of HIV infection on morbidity and mortality, to allocate medical care resources and services, and to guide prevention and disease control activities.
HIV/AIDS case reports are sent to state/local health departments by laboratories, physicians, hospitals, clinics, and other health care providers. Areas use a microcomputer system developed by CDC (the HIV/AIDS Reporting System, HARS) to store and analyze data, as well as transmit encrypted data to CDC. An improved HIV reporting system (eHARS) is currently in development and is scheduled to replace HARS during the period of this clearance.
We anticipate making a modification to the layout of both the Adult and the Pediatric HIV/AIDS confidential case report forms during this period which would include the addition of a blank space in the top portion and bottom portion of the forms. Areas could then have the option of using this space to assign a local form number. This form number would be for local use only and not be reported to CDC.
The burden estimate for this revision includes estimated burden for evaluations of HIV/AIDS surveillance and case report updates. In addition, the burden estimate also includes additional data on HIV testing and treatment history for the purpose of estimating HIV incidence. The availability of a serologic testing algorithm for recent HIV seroconversion (STARHS) allows surveillance systems to determine how many among a group of new diagnoses are from new infections. In order to derive a population-based estimate of HIV incidence based on data from those individuals who choose to have an HIV antibody test and who test positive (those reported to HIV surveillance systems), additional data are needed to assign statistical weights to individual STARHS results. These additional data include STARHS results, information on testing reason, frequency, location, dates tested, prior positive and negative tests, and use of HIV-related medicines.
The table also includes burden estimates of additional information requested on specimen quality and genotyping test results for drug resistance and HIV-1 subtypes as part of variant, atypical and resistant HIV surveillance (VARHS). These data will be reported to CDC by participating health departments for the purpose of calculating population-based estimates of prevalence of HIV drug resistance and HIV-1 subtypes among individuals with newly diagnosed HIV.
The burden estimate also includes enhanced data collection on HIV-infected mothers and their infants in 15 areas. Proposed data collection for enhanced perinatal surveillance (EPS) will supplement information collected on both the adult and pediatric case report form and include data on prenatal care, clinical history, testing, and antiretroviral therapy. These clinical and behavioral data will be used to better monitor the effects of HIV testing, prevention, and treatment guidelines and to maximally reduce perinatal HIV transmission.
No other Federal agency collects this type of national HIV/AIDS data. In addition to providing technical assistance for use of the case report forms, CDC also provides reporting areas with technical support for the HARS software. There is no cost to respondents. The total estimated annual burden hours are 57,774. Start Printed Page 66531
|Type of respondent||Form name||Number of respondents||Average number of responses per respondent||Average burden per response (in hours)|
|State Health Departments||Adult Case Report: AIDS||59||890||20/60|
|Adult Case Report: HIV||59||932||20/60|
|State Health Departments||Peds Case Report: AIDS||59||3||20/60|
|Peds Case Report: HIV||59||11||20/60|
|State Health Departments||Case Report Updates||59||85||5/60|
|State Health Departments||Incidence||30||2,833||10/60|
|State Health Departments||VARHS||24||2,917||5/60|
|State Health Departments||EPS||15||200||25/60|
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. E6-19258 Filed 11-14-06; 8:45 am]
BILLING CODE 4163-18-P